Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.
about
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyA novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study.High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancerRadiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses.N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.Reconstruction of Large Perineal and Pelvic Wounds Using Gracilis Muscle Flaps.Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.Trial Watch: Radioimmunotherapy for oncological indications.A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer.BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
P2860
Q27004011-0B62D8C1-36EB-4437-8814-18158E7CC207Q35755378-E2D0B434-C888-429D-8B89-AF696E576339Q35782071-64277CCF-0688-461A-A134-49282C1E6F65Q36151978-4860AB9C-B45C-468D-B516-8E73DFD4B451Q36738615-BC925076-7489-4AEB-AB4E-4E7793D99D23Q37665639-46389998-A74F-4744-B200-EEF4F5DF3714Q37707552-2870BEE8-9D1F-48DF-999A-B9AF4FE2377EQ38767402-64CBA848-BB8B-417D-973D-2DBF71341F44Q41468696-160924AB-3CC0-45FD-BB56-6D874B740BCFQ43054579-52DB6444-AAA5-47B0-B2DC-CC09A752F8BDQ43104064-88F754AC-D552-4BCA-8C1D-BB2BBD5352B6Q47126907-A2A8F19E-2EF3-4738-AAAE-FD023E0ECC90Q51013700-4999984D-FA76-4153-93A3-AFB2690B78B8
P2860
Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@en
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@nl
type
label
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@en
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@nl
prefLabel
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@en
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@nl
P2093
P2860
P356
P1476
Clinical outcome of neoadjuvan ...... ocally advanced rectal cancer.
@en
P2093
Guan-Nan Zhang
Guo-Le Lin
Hui-Zhong Qiu
Jun-Yang Lu
P2860
P304
P356
10.1002/JSO.23394
P577
2013-08-01T00:00:00Z